Pharmaceutical company Mylan is facing intense public scrutiny over the pricing of its EpiPens.
The Tylt, Staten Island Advance
Fri, 08/26/2016 - 3:00pm
Pharmaceutical company Mylan is facing intense public scrutiny over the pricing of its EpiPens.